IRD Cash Flow Breakdown | Opus Genetics, Inc.

Opus Genetics, Inc. Cash Flow Breakdown

Cash flow breakdown shows where Opus Genetics, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

Fiscal year ended 2025-12-31: from running the business, $35.25M went out.
Fiscal year ended 2025-12-31: from investing, $0.00 came in.
Fiscal year ended 2025-12-31: from financing, $50.02M came in.
Fiscal year ended 2025-12-31: change in cash, $14.77M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year end	Running the business	From investing	Buybacks	New debt	New shares sold	Not split out	Change in cash
2025-12-31	-$35.25M	$0.00			$5.80M	$44.22M*	$14.77M
2024-12-31	-$25.58M	$1.21M			$4.50M		-$20.18M
2023-12-31	-$1.11M	$0.00			$9.23M		$7.87M
2022-12-31	$14.31M	$0.00			$4.43M	-$642.00K*	$18.10M
2021-12-31	-$19.37M	-$100.00K			$28.49M	-$886.00K*	$8.13M
2020-12-31	-$6.80M	$539.00K			$0.00	$21.12M*	$14.86M
2019-12-31	-$3.59M	-$25.00K			$7.65M	-$2.95M*	$1.09M
2018-12-31	-$18.84M	$11.91M			$6.87M		-$154.85K
2017-12-31	-$15.42M	-$9.37M			$16.68M	$5.43M*	-$2.68M
2016-12-31	-$13.23M	$4.48M				$10.12M*	$1.38M
2015-12-31	-$17.35M	$9.55M			$1.04M	$7.13M*	$373.19K
2014-12-31	-$11.04M	-$22.66M			$258.95K	$24.58M*	-$8.86M
2013-12-31	-$7.98M	$845.52K	$0.00*	$0.00*	$90.00K	$12.25M*	$5.20M
2012-12-31	-$6.62M	$2.19M	$0.00*	$0.00*	$0.00*	$8.05M*	$3.63M
2011-12-31	-$15.53M	-$545.92K	$0.00	$0.00	$59.24K	$13.54M*	-$2.48M
2010-12-31	-$6.99M	-$660.04K	$0.00	$0.00	$107.24K	$12.58M*	$5.04M
2009-12-31	-$5.15M	$1.34M	$0.00	$0.00	$3.60K	$10.73M*	$6.93M

Each quarter (3 month)

Quarter end	Running the business	From investing	Buybacks	New debt	New shares sold	Not split out	Change in cash
2026-06-30	-$11.95M*	$0.00*			$0.00*	$40.90M*
2026-03-31	-$12.73M	$0.00			$2.25M	$25.34M*	$14.87M
2025-12-31	-$9.83M*	$0.00*			$179.00K*	$23.93M*
2025-09-30	-$6.16M*	$0.00*			$5.22M*	-$674.00K*
2025-06-30	-$10.27M*	$0.00*			$0.00*	$906.00K*
2025-03-31	-$8.99M	$0.00			$409.00K	$20.06M*	$11.47M
2024-12-31	-$7.44M*	$1.21M*			$0.00*
2024-09-30	-$5.13M*	$0.00*			$456.00K*
2024-06-30	-$7.29M*	$0.00*			$1.56M*
2024-03-31	-$5.72M	$0.00			$2.48M		-$3.34M
2023-12-31	$4.55M*	$0.00*			$3.75M*
2023-09-30	-$3.00M*	$0.00*			$5.48M*
2023-06-30	$989.00K*	$0.00*			$0.00*
2023-03-31	-$3.65M	$0.00			$0.00		-$3.65M
2022-12-31	$28.79M*	$0.00*			$0.00*
2022-09-30	-$4.50M*	$0.00*			$0.00*	$1.33M*
2022-06-30	-$3.81M*	$0.00*			$0.00*	$1.59M*
2022-03-31	-$6.17M	$0.00			$27.00K	$855.00K*	-$5.29M
2021-12-31	-$5.65M*	-$100.00K*			$1.00K*	$8.03M*
2021-09-30	-$3.58M*	$0.00*			$76.00K*	$1.52M*
2021-06-30	-$4.33M*	$0.00*			$0.00*	$17.96M*
2021-03-31	-$5.81M	$0.00			$10.00K		-$5.80M
2020-12-31	-$4.36M*	$539.00K*			$58.00K*	$19.44M*
2020-09-30	-$1.06M*	$0.00*			$0.00*	$924.00K*
2020-06-30	-$651.00K*	$0.00*			$0.00*
2020-03-31	-$732.00K	$0.00			$0.00		-$284.00K
2019-12-31	$4.97M*	-$123.55K*			$0.00*	-$2.95M*
2019-09-30	-$2.38M*	$3.00M*			$0.00*
2019-06-30	-$1.81M*	$2.99M*			$0.00*
2019-03-31	-$4.38M	-$5.90M			$7.65M		-$2.62M
2018-12-31	-$4.62M*	$2.00M*					$4.15M*
2018-09-30	-$4.17M*	$3.66M*					-$502.55K*
2018-06-30	-$4.45M*	$3.25M*					-$1.20M*
2018-03-31	-$5.60M	$3.00M					-$2.60M
2017-12-31	-$3.70M*	-$3.06M*			$0.00*	$7.44M*	$672.97K*
2017-09-30	-$3.45M*	$3.00M*			$0.00*		-$564.33K*
2017-06-30	-$4.10M*	-$10.02M*				$12.42M*	-$1.70M*
2017-03-31	-$4.17M	$710.34K				$2.37M*	-$1.09M
2016-12-31	-$1.49M*	$4.68M*					$3.19M*
2016-09-30	-$3.12M*	-$1.91M*				$5.54M*	$514.25K*
2016-06-30	-$5.06M*	$2.48M*					-$2.59M*
2016-03-31	-$3.55M	-$766.36K				$4.58M*	$264.21K
2015-12-31	-$4.41M*	-$4.28M*			$36.86K*	$6.40M*	-$2.25M*
2015-09-30	-$4.50M*	$6.96M*			$0.00*		$2.48M*
2015-06-30	-$4.40M*	$2.64M*			$3.08K*	$1.01M*	-$758.56K*
2015-03-31	-$4.04M	$4.24M			$705.54K		$902.97K
2014-12-31	-$2.91M*	-$2.23M*			$0.00*		-$5.15M*
2014-09-30	-$2.60M*	-$20.53M*			$0.00*		-$23.13M*
2014-06-30	-$2.95M*	$74.93K*			$188.96K*	$718.75K*	-$1.97M*
2014-03-31	-$2.58M	$28.83K	$0.00*	$0.00*	$70.00K	$23.86M*	$21.38M
2013-12-31	-$2.25M*	$309.36K*	$0.00*	$0.00*	$0.00*	$5.76M*	$3.82M*
2013-09-30	-$1.68M*	$14.85K*	$0.00*	$0.00*	$90.00K*	$6.47M*	$4.89M*
2013-06-30	-$2.50M*	$387.30K*	$0.00*	$0.00*	$0.00*		-$2.09M*
2013-03-31	-$1.55M	$134.01K	$0.00*	$0.00*	$0.00*		-$1.42M
2012-12-31	-$1.07M*	-$874.63K*	$0.00*	$0.00*	$0.00*	$8.05M*	$6.11M*
2012-09-30	-$1.65M*	$546.72K*	$0.00*	$0.00*	$0.00*		-$1.10M*
2012-06-30	-$1.98M*	$2.36M*	$0.00*	$0.00*	$0.00*		$381.87K*
2012-03-31	-$1.92M	$156.13K	$0.00	$0.00	$0.00		-$1.76M
2011-12-31	-$4.88M*	$1.50M*	$0.00*	$0.00*	$19.20K*		-$3.36M*
2011-09-30	-$3.16M*	$228.19K*	$0.00*	$0.00*	$22.04K*		-$2.91M*
2011-06-30	-$5.06M*	$679.40K*	$0.00*	$0.00*	$0.00*		-$4.39M*
2011-03-31	-$2.43M	-$2.96M	$0.00	$0.00	$18.00K	$13.54M*	$8.17M
2010-12-31	-$2.42M*	-$1.07M*	$0.00*	$0.00*	$0.00*		-$3.49M*
2010-09-30	-$1.59M*	-$395.81K*	$0.00*	$0.00*	$0.00*		-$1.99M*

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
RELMADA THERAPEUTICS, INC. (RLMD)	United States	$0.406B	-11.92
Arcturus Therapeutics Holdings Inc. (ARCT)		$0.402B	-2.05
GALECTIN THERAPEUTICS INC (GALT)	United States	$0.399B	-11.06
ARS Pharmaceuticals, Inc. (SPRY)	United States	$0.414B	-3.70
Atea Pharmaceuticals, Inc. (AVIR)	United States	$0.414B	-2.26
Turn Therapeutics Inc. (TTRX)	United States	$0.397B	-25.68
DiaMedica Therapeutics Inc. (DMAC)	United States	$0.423B	-10.11
PROTHENA CORP PUBLIC LTD CO (PRTA)	Ireland	$0.428B	-11.53
Rezolute, Inc. (RZLT)	United States	$0.382B	-6.45
CYPHERPUNK TECHNOLOGIES INC. (CYPH)	United States	$0.438B	-75.63